These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34622442)

  • 1. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.
    Fujii S; Ishibashi T; Kokura M; Fujimoto T; Matsumoto S; Shidara S; Kurppa KJ; Pape J; Caton J; Morgan PR; Heikinheimo K; Kikuchi A; Jimi E; Kiyoshima T
    J Pathol; 2022 Jan; 256(1):119-133. PubMed ID: 34622442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise activation of p63 and the MEK/ERK pathway induces the expression of ARL4C to promote oral squamous cell carcinoma cell proliferation.
    Alkhatib DZR; Thi Kim Truong T; Fujii S; Hasegawa K; Nagano R; Tajiri Y; Kiyoshima T
    Pathol Res Pract; 2023 Jun; 246():154493. PubMed ID: 37141698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
    Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
    Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
    Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
    Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
    Matsumoto S; Fujii S; Kikuchi A
    J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arl4c is involved in tooth germ development through osteoblastic/ameloblastic differentiation.
    Truong TTK; Fujii S; Nagano R; Hasegawa K; Kokura M; Chiba Y; Yoshizaki K; Fukumoto S; Kiyoshima T
    Biochem Biophys Res Commun; 2023 Oct; 679():167-174. PubMed ID: 37703759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
    Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
    Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
    Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors.
    Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T
    Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
    Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
    Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
    Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
    J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.
    Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K
    Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis.
    Fujii S; Kiyoshima T
    Pathol Int; 2023 Jun; 73(6):217-233. PubMed ID: 37098842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.
    Wu X; Simpson J; Hong JH; Kim KH; Thavarajah NK; Backx PH; Neel BG; Araki T
    J Clin Invest; 2011 Mar; 121(3):1009-25. PubMed ID: 21339642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα.
    Varga A; Ehrenreiter K; Aschenbrenner B; Kocieniewski P; Kochanczyk M; Lipniacki T; Baccarini M
    Sci Signal; 2017 Mar; 10(469):. PubMed ID: 28270557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities.
    Kawauchi K; Lazarus AH; Sanghera JS; Man GL; Pelech SL; Delovitch TL
    Mol Immunol; 1996 Feb; 33(3):287-96. PubMed ID: 8649450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.